Table 1 Single dose pharmacokinetics of nirmatrelvir or nirmatrelvir/ritonavir in Roborovski dwarf hamster and human plasma

From: Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models

Drug

Species

Dose (mg/kg)

Tmax (h)

Cmax (ng/ml)

AUCinf (hours × ng/ml)

t1/2 (h)

Reference

Nirmatrelvir/ ritonavir

Roborovski dwarf hamster

250/83

1

34,200

215,000

2.21

This study

Nirmatrelvir

Roborovski dwarf hamster

250

1

5320

22,400

1.36

This study

Nirmatrelvir/ ritonavir

Human

250/100a

2.75

2882

28,220

6.94

34

Molnupiravir

Human

800a

1.75

2770

8200

1.18

36

Molnupiravir

Roborovski dwarf hamster

250

0.5

251

376

1.62

29

  1. aHuman doses are expressed as absolute amount, not mg/kg.